Tamares Group

Tamares Group is a private investment firm and family office based in London, United Kingdom, with a diversified portfolio that includes significant interests in real estate, technology, manufacturing, leisure, and media. Established in 1990, the firm focuses primarily on real estate investments, particularly in multi-family properties across the United States, Europe, and the Middle East. In addition to its real estate activities, Tamares also invests in operating businesses, engaging in both passive and active investment strategies. Through its varied investments, Tamares aims to create value across multiple sectors and regions.

Shlomo Zabludowicz

Founder

13 past transactions

Singa

Seed Round in 2017
Singa is the Spotify of karaoke for personal and commercial use. Access a catalog of 20 000+ songs to sing effortlessly anywhere, any time and with any platform. Easy to use is Singa’s main operating principle. You don’t need to buy a console, or a microphone, or even a DVD-player. Singa is platform agnostic. To use Singa, you’ve already got everything you need either in your pocket (mobile phone), on your table (PC) or in your living room (TV). * One account works on all devices, mobile, browser or Smart TV * Each user gets to test Singa for free before signing up to a Premium account * Singa works fluently with external accessories

Aves Netsec

Seed Round in 2017
Aves Netsec is a cybersecurity company. The company protects information assets of companies from unsolicited visitors. Its solution adds a new layer of security to the network which negates attacker from the ability to function. Capturing attackers and drawing intelligence from them with the Aves solution enables enterprises to understand attacker motives, build risk profiles and quantify attack impacts and subsequently improve their security posture. Aves Netsec the company was founded by Simo Kohonen in 2014 and is headquartered in London, England.

Plate IQ

Series A in 2017
Plate IQ is accounts payable automation software designed for restaurants. It saves time, increases data accuracy, and provides insight into spend by extracting line item data from invoices and automatically coding purchases to GL accounts. Invoice data also powers: *Approvals - Create custom approval policies for invoices. *Bill Pay - Manage payments via ACH or paper check. *Statements - Reconcile vendor statements automatically. *Reporting - Gain up-to-date cost and vendor pricing insights. Plate IQ integrates with top accounting and inventory software, virtually eliminating data entry from the AP process.

Mezmo

Venture Round in 2016
Mezmo, formerly known as LogDNA, Inc., is a cloud-based log management company based in Mountain View, California, with an additional office in Toronto, Canada. Founded in 2013, Mezmo offers a centralized log management solution that allows engineering and DevOps teams to collect, aggregate, and analyze system and application logs in real-time. The platform supports various deployment options, enabling users to ingest and view log data from diverse environments, including AWS, Docker, and Heroku, with minimal onboarding time. Mezmo's solution is adaptable for self-hosted, cloud, and multi-cloud infrastructures, facilitating seamless log transmission via Syslog, code libraries, or agents.

AImotive

Series B in 2016
AImotive Informatikai Kft. specializes in artificial intelligence-driven self-driving technology designed for human drivers. Founded in 2015 and based in Budapest, Hungary, the company leverages camera-based solutions that replicate human visual capabilities. AImotive offers a suite of products, including aiDrive, which provides global self-driving functionalities across various weather conditions, and aiSim, which enables developers to test self-driving software effectively. Additionally, their aiWare product consists of AI-optimized hardware that is scalable for both embedded solutions and data centers. By combining expertise in artificial intelligence, sensor fusion, and 3D graphics, AImotive aims to support industry partners in achieving their autonomous driving objectives, fostering collaboration with its modular and hardware-agnostic solutions.

Siklu

Series D in 2015
Siklu Communication Ltd. is a company based in Petach Tikva, Israel, that specializes in developing gigabit throughput E-band and V-band radios for a diverse range of clients, including service providers, mobile operators, enterprises, and government entities. Founded in 2007, Siklu offers various wireless communication solutions, such as small cell backhaul, LTE/LTE-A backhaul, WiFi backhaul, and business broadband connectivity. The company focuses on providing reliable millimeter wave radio products that support 5G backhaul applications, enhancing connectivity in urban, suburban, and rural settings. Siklu's technology is designed to deliver scalable, multigigabit capacity and performance, making it suitable for smart city networks, wireless security networks, enterprise connectivity, and residential broadband services.

AImotive

Series A in 2015
AImotive Informatikai Kft. specializes in artificial intelligence-driven self-driving technology designed for human drivers. Founded in 2015 and based in Budapest, Hungary, the company leverages camera-based solutions that replicate human visual capabilities. AImotive offers a suite of products, including aiDrive, which provides global self-driving functionalities across various weather conditions, and aiSim, which enables developers to test self-driving software effectively. Additionally, their aiWare product consists of AI-optimized hardware that is scalable for both embedded solutions and data centers. By combining expertise in artificial intelligence, sensor fusion, and 3D graphics, AImotive aims to support industry partners in achieving their autonomous driving objectives, fostering collaboration with its modular and hardware-agnostic solutions.

PushMarket

Seed Round in 2014
Answerbook automates and personalizes email marketing for eCommerce. Answerbook's predictive intelligence engine analyzes consumer behavior on email, website and purchase history. With this information, Answerbook automatically sends relevant follow up emails to consumers.

N-trig

Series F in 2013
N-Trig is a startup founded in 1999 that specializes in the development of touch screens and pen styluses, particularly its Duosense active pen, which allows users to annotate on screens in a way that mimics writing on paper. The company holds an extensive patent portfolio and caters to various market segments, including consumer electronics, education, business, healthcare, graphic design, gaming, and multimedia. N-Trig operates globally, with its research and development facility, corporate headquarters, and management located in Kfar Saba, Israel. It also has sales, OEM, and independent software vendor support in Austin, Texas, and San Jose, California, while its operations and supply chain support are based in Taipei, Taiwan, Tokyo, Japan, and Shanghai, China.

N-trig

Series E in 2012
N-Trig is a startup founded in 1999 that specializes in the development of touch screens and pen styluses, particularly its Duosense active pen, which allows users to annotate on screens in a way that mimics writing on paper. The company holds an extensive patent portfolio and caters to various market segments, including consumer electronics, education, business, healthcare, graphic design, gaming, and multimedia. N-Trig operates globally, with its research and development facility, corporate headquarters, and management located in Kfar Saba, Israel. It also has sales, OEM, and independent software vendor support in Austin, Texas, and San Jose, California, while its operations and supply chain support are based in Taipei, Taiwan, Tokyo, Japan, and Shanghai, China.

N-trig

Series E in 2011
N-Trig is a startup founded in 1999 that specializes in the development of touch screens and pen styluses, particularly its Duosense active pen, which allows users to annotate on screens in a way that mimics writing on paper. The company holds an extensive patent portfolio and caters to various market segments, including consumer electronics, education, business, healthcare, graphic design, gaming, and multimedia. N-Trig operates globally, with its research and development facility, corporate headquarters, and management located in Kfar Saba, Israel. It also has sales, OEM, and independent software vendor support in Austin, Texas, and San Jose, California, while its operations and supply chain support are based in Taipei, Taiwan, Tokyo, Japan, and Shanghai, China.

Panaya

Series B in 2009
Panaya, an Infosys company, is the leader in SaaS-based change automation and testing for SAP, Oracle and Salesforce. Panaya provides cloud-based application delivery, and testing solutions that ensure collaboration between Business and IT. Enabling enterprise agility with faster release velocity and uncompromising quality, Panaya delivers an optimized user experience with end-to-end visibility of the application lifecycle. Since 2008, 2,000 companies in 62 countries, including a third of the Fortune 500, have been using Panaya to deliver quick quality change to enterprise applications.

Protalix Biotherapeutics

Series C in 2005
Protalix Biotherapeutics is a biopharmaceutical company based in Karmiel, Israel, that specializes in the development and commercialization of recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based protein expression system. The company is primarily known for its product Elelyso, a recombinant glucocerebrosidase enzyme approved for the treatment of Gaucher disease. Protalix is advancing a diverse pipeline, including PRX-102, which is in phase III clinical trials for Fabry disease, and OPRX-106, a therapeutic candidate for inflammatory bowel disease that has completed phase IIa trials for ulcerative colitis. Additionally, PRX-110, aimed at treating cystic fibrosis, and PRX-115, a treatment for gout, are also in development. Protalix has established partnerships with leading pharmaceutical companies, including Pfizer, and has a commercial presence in Brazil and other regions of Latin America. The company aims to target significant pharmaceutical markets with its innovative therapies for genetic and inflammatory disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.